Designed and created by Guideline Central in participation with the American Association of Hip and Knee Surgeons
Gabapentinoids in Total Joint Arthroplasty
Patient Guideline Summary
Publication Date: March 1, 2020
Last Updated: March 3, 2023
Objective
Objective
This patient summary means to discuss key recommendations from the American Association of Hip and Knee Surgeons, American Society of Regional Anesthesia and Pain Medicine, American Academy of Orthopaedic Surgeons, Hip Society, and Knee Society for gabapentinoids in total joint arthroplasty. It is limited to adults 18 years of age and older and should not be used as a reference for children.